Fairmount Funds Management LLC → Oruka Therapeutics, Inc. ORKA

Stake: 19.99% Shares: 8,511,824 CUSIP: 687604108 Class: Common Stock, $0.001 par value

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

0 buys · 0 sales · 1 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 5.02

4,522,980 shares short · +24.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $18.19M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-15	Goncalves Joana	officer	Option exercise	3,500	$6.84	$24K

Other 13D/G Filings on Oruka Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2022-07-08	SC	Funicular Funds, LP	—	—	view →
2018-03-05	SC	Growth Equity Opportunities IV, LLC	—	—	view →
2018-01-04	SC	SABBY MANAGEMENT, LLC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →